and indicated a greater fear of injection and social stigmatization in using insulin than men (21.1%).
This result is of particular concern because women with diabetes are at greater risk of diabetesassociated coronary heart disease than men. 5 ethnic minorities had greater psychological insulin resistance than Caucasians. Asians had significantly higher fear of injections and expected greater hardship in using insulin than Caucasians.
other minority groups, including hispanics, American indians, and Pacific islanders, also had significantly higher fear of injection than Caucasians. 4 in addition to cultural issues that can create barriers to initiating insulin therapy, research suggests that low levels of literacy and numeracy are associated with poorer health outcomes and levels of treatment adherence. 6 For people with diabetes, this is even more challenging. 
Discuss the Real Risks of Hypoglycemia
Teach your patients how to prevent, recognize, and treat hypoglycemia. Frequent blood glucose monitoring and a careful review of results can reduce the risk of potential problems.
Enhance Self-Efficacy (Self-Esteem or Confidence) as Quickly as Possible
Self-efficacy is "the belief in one's capabilities to organize and execute the courses of action required to manage prospective situations." 1. Listen carefully to negative attitudes that your patients may report. acknowledge and validate their feelings. Develop a therapeutic alliance using a patient-centered approach that is individualized and responsive to specific psychological stresses.
2. maintain cultural and gender sensitivity and consider literacy and numeracy skills. the Diabetes numeracy test (available on the vanderbilt university website) offers a simple unambiguous way to conduct an assessment without causing distress or embarrassment.
3. encourage patients to recognize insulin as an effective therapeutic tool. explain that given the progressive decline in beta cell function in t2Dm, good glycemic control often requires insulin therapy.
4. try "blaming" the patient's pancreas to remove feelings of guilt and self-blame. reassure patients that starting insulin therapy is not a failure of their efforts and that they have been "bad."
5. teach patients the progressive nature of t2Dm using analogies. For example, note how aging eyes may need glasses to see and aging ears may need hearing aids to hear. similarly, as the pancreas gets older, insulin may be needed to help it do its job.
6. explain that the risk of hypoglycemia is low (0.5%) with the new insulins. of course, it is still important to teach hypoglycemia awareness and treatment.
7. enhance patient self-confidence about learning the skills necessary to initiate insulin therapy. support the patient's positive self-efficacy beliefs and optimism to help reduce anxiety. recommend Dsme classes or a support group where patients can learn from each other.
8. use the importance-confidence ruler to quickly obtain a good idea of the patient's readiness to change and whether to focus initially on exploring the importance of changing or building confidence in the patient's ability to change.
9. engage patients in goal setting and decision making to help patients feel informed, empowered, and equipped to confidently manage the daily demands of insulin therapy.
10. recognize that overcoming psychological insulin resistance may take time, but in the process, patients can gain control over their diabetes and achieve their personal treatment goals. The mi process includes the following.
Shared Agenda Setting
The Cde elicits from the patient their preferences regarding the focus of treatment. The patient's concerns are tackled first, followed by the concerns of the Cde, in a negotiated fashion. Agenda setting can be limited to a fixed list of 2 or 3 topics (eg, initiate insulin therapy, food issues, exercise issues).
Asking Open-Ended Questions
The 
